Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Teva | Epoetin theta | Biopoin | 2009-10-23 | |||
Roche | Methoxy polyethylene glycol-epoetin beta | Mircera | 2007-07-20 | $496.403 M | Q4/22-Q3/23 | |
Epoetin beta | NeoRecormon | 1997-07-16 | ||||
Sandoz | Epoetin alfa | Binocrit | 2007-08-28 | |||
Organon | Nandrolone | Durabolin | 1982-01-01 | |||
Pfizer | Epoetin zeta | Retacrit | 2007-12-18 | $340 M | Y2023 | |
Voxelotor | Oxbryta | 2022-02-14 | $328 M | Y2023 | ||
Takeda | Ferumoxytol | Rienso | 2012-06-15 | |||
Bristol Myers Squibb | Luspatercept | Reblozyl | 2020-06-25 | $1,773 M | Y2024 | |
Astellas Pharma | Roxadustat | Evrenzo | 2021-08-18 | |||
Woodward Pharma Services | Nandrolone decanoate | Deca-durabolin | 1986-06-12 |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|